Clinical Trial Update: Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). [Phase 3]

View source ↗

Summary

Phase 3 trial comparing low molecular weight heparin/edoxaban tosylate to LMWH/warfarin for venous thromboembolism treatment, including deep vein thrombosis and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)
• edoxaban tosylate (edoxaban)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Venous Thromboembolism, Deep Vein Thrombosis (DVT) | Phase 3 | Status: COMPLETED | Results posted: 2015-02-25